Dublin, Ireland · Founded 2016 · Privately Held (backing)
Developer of an anti-aging therapeutics designed to extend healthy lifespan by targeting core aging mechanisms. Juvenescence is based in Dublin, Ireland and was founded in 2016. Its last reported valuation was $502 million in Aug 2019. It has raised $341 million across 4 recorded rounds; the latest was a $9.4 million early-stage round in Dec 2020.
Last reported valuation
$502.0M
Oct 2026
Priced at
—
Total raised
$340.7M
Last round
Early Stage VC
Dec 2020
No prints on record
No secondary trades in Juvenescence shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Juvenescence with a free account
·The complete investor list: 18 names
·Watch Juvenescence: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Juvenescence stock.
